Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving nuclear, medical, defense, and research end markets. This news page aggregates company press releases and third-party coverage so readers can follow how Mirion’s activities in radiation safety, science, and medicine develop over time.
Recent Mirion news has highlighted its role in the nuclear power sector and capital markets. The company announced a definitive agreement to acquire, and later the completion of the acquisition of, Paragon Energy Solutions, a provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors in the United States. News releases describe how Paragon’s systems and solutions are present in all nuclear reactors in North America and how the acquisition is intended to broaden Mirion’s portfolio for nuclear power customers, including SMRs, within the Mirion Nuclear & Safety group.
Investors and observers can also find updates on Mirion’s financial performance and financing activities. The company issues quarterly earnings press releases, such as its announcement of third quarter 2025 results, and provides guidance commentary. Additional news covers public offerings of Class A common stock, convertible senior notes offerings, and related financing steps to support acquisitions and general corporate purposes.
Beyond transactions and earnings, Mirion’s news flow includes strategic collaborations. A notable example is its partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA) to cooperate in radiation detection and measurement, including support for the IAEA’s Terrestrial Environmental Radiochemistry Laboratory. For ongoing insight into MIR stock-related developments, nuclear and medical segment updates, and regulatory or partnership announcements, readers can review this news feed regularly.
Mirion Technologies (NYSE: MIR) will release its financial results for the first quarter of 2022 on May 4, 2022, followed by a conference call at 11:00 am ET. Participants can join by calling 1-844-826-3033 or 1-412-317-5185. A live webcast will also be available at Mirion's Investor page. A telephonic replay will be accessible until May 18, 2022. Mirion is a leader in detection, measurement, and analysis solutions for various markets, including nuclear and medical, employing around 2,600 people across 13 countries.
Mirion Technologies (NYSE: MIR) has announced an upgraded Cloud-hosted, SaaS option for its SunCHECK™ Quality Management Platform. This platform enhances workflows for Radiation Therapy Quality Assurance, improving patient safety and reducing operational burdens. The SaaS model offers better scalability and reliability, utilizing Amazon Web Services for infrastructure. Over 1,600 users currently utilize SunCHECK software, showcasing its significance in cancer care. The SaaS solution is designed to meet diverse clinic needs and will be demonstrated at ESTRO 2022 in Copenhagen.
Mirion Technologies reported a 18% increase in revenue for Q4 2021, totaling $177.8 million, compared to $150.8 million in Q4 2020. The company posted a GAAP net loss of $23.0 million for the same period. Adjusted EBITDA rose to $44.5 million, up from $31.2 million in the previous quarter. For the fiscal year 2022, Mirion forecasts adjusted revenue growth between 5.5% and 7.5% and adjusted EBITDA of $175 million to $185 million. The company is facing supply chain challenges but remains confident in its growth prospects.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Citi Global Industrial Tech and Mobility Conference in Miami, FL, on February 24, 2022, at 1:50 PM ET. The presentation will be webcast live, with an archived version available afterward. Mirion is a premier provider of detection and monitoring solutions for nuclear, defense, and medical sectors and operates in 13 countries, employing around 2,600 people. For additional details, visit Mirion.com.
Mirion Technologies, Inc. (NYSE: MIR) will release its financial results for the fourth quarter and fiscal year ended December 31, 2021 on February 23, 2022. A conference call to discuss these results will take place on the same day at 10:00 am ET. Investors can join by calling 1-877-407-9208 or via webcast at Mirion's investor relations website. A telephonic replay will be available until March 9, 2022.
Kaman Composites – Vermont, a subsidiary of Kaman Corporation (NYSE:KAMN), has partnered with Mirion Technologies (NYSE:MIR) to expand its medical imaging program. This collaboration involves Kaman supplying surgical C-Arm tabletops, with the first deliveries scheduled for Q2 2022. Kaman Composites possesses 40 years of expertise in designing composite components and is recognized for its rigorous manufacturing standards. This partnership signifies Kaman's growing presence in the medical technology sector while maintaining its aerospace industry role.
Sun Nuclear Corporation, a subsidiary of Mirion Technologies (NYSE: MIR), has announced the full program for the 2022 QA & Dosimetry Symposium (QADS), scheduled for April 8-9 in Orlando, Florida. The event will focus on Quality and Patient Safety in Radiation Oncology, featuring six session themes and over 20 presentations. Topics include Cybersecurity in Healthcare and Practical Dosimetry. Notably, the symposium will address challenges posed by cyberattacks and the COVID-19 pandemic. Registration is open until January 21, 2022.
Mirion Technologies (NYSE: MIR) has launched the Hyperion™ Compact Digital High Radiation Tolerant Camera, available in color and monochrome versions. This innovative camera enhances digital performance while reducing the cost of ownership, making it ideal for surveillance and high radiation environments, including nuclear power plants. The Hyperion Compact boasts improved durability, significant performance advancements, and a total integrated dose specification of 100 megarads. This development underscores Mirion's commitment to growth in the nuclear power sector.
Mirion Technologies, Inc. (NYSE: MIR) has completed the acquisition of Computerized Imaging Reference Systems, Inc. (CIRS) for approximately $54 million. CIRS specializes in medical imaging and radiation therapy phantoms, crucial for calibrating diagnostic equipment, measuring radiation doses, and ensuring quality assurance in medical settings. This strategic move is expected to enhance Mirion's Medical segment and improve patient outcomes. However, risks exist regarding integration challenges and anticipated benefits may not fully materialize.
Mirion Technologies (NYSE: MIR) reported a 26% increase in GAAP revenues for Q3 2021, totaling $144.3 million, up from $114.6 million in Q3 2020. However, net loss rose 15.8% to ($46.7) million. Adjusted revenues climbed 29% to $148 million, with Adjusted EBITDA at $30.9 million, a 28% increase. The Medical segment saw a significant revenue increase of 155%. Organic growth was a slight (0.1%) compared to 8.5% in the prior year. Mirion completed its business combination with GS Acquisition Holdings Corp II on October 20, 2021, enhancing liquidity to approximately $230 million.